Navigation Links
BioMarin to Present at the Cowen and Company 29th Annual Health Care Conference
Date:3/10/2009

NOVATO, Calif., March 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey H. Cooper, Senior Vice President and Chief Financial Officer of BioMarin, will present a company update at the Cowen and Company 29th Annual Health Care Conference in Boston on Tuesday, March 17th, 2009 at 9:30 a.m. ET.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase 1 clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press r
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BioMarin to Present at the Barclays Capital Global Healthcare Conference
2. BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
3. BioMarin Supports Observance of Rare Disease Day February 28
4. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference
5. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
6. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
7. BioMarin to Present at the Lehman Brothers Global Healthcare Conference
8. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
9. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
10. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
11. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... New York, NY (PRWEB) December 22, 2014 ... a noticeable toll and can present in the form ... nasolabail folds with the start of the marionette line ... peels, topical treatments and diligent skincare, but as the ... Radiesse, and Restylane are all synthetic fillers that can ...
(Date:12/22/2014)... Sagacious Consultants, the premier full-service Epic ... to their ad hoc report writing service to meet ... sign up for an annual subscription and get a ... a deeply discounted hourly rate. , Customers can ... progressively discounted rate. Subscription hours are contracted in 25 ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The holidays are ... of the season. Many may be thinking about how to ... of a few weeks. Health Republic Insurance of New York ... Dietitian, Andrea Chernus, to provide some smart ideas to enjoy ... healthy. , 1)    Avoid arriving at a holiday gathering over-hungry , ...
(Date:12/22/2014)... new vaccine created to fight an illness similar to ... and even humans from similar brain infections, researchers report. ... becoming infected by the incurable brain disorder known as ... Dec. 21 online edition of the journal Vaccine ... particles known as prions that go rogue. Prion ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Super Saturday, ... Friday this year as the busiest day in the ... retailers, The Grass Station had a steady pre-Christmas stream ... gifts, this past Saturday. , “I definitely intend to ... Robert, a Denver resident who was enjoying The Grass ...
Breaking Medicine News(10 mins):Health News:Sam Rizk, MD, FACS, Introduces Rapid Recovery Facelift 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:Health Republic Insurance of New York Offers Five Simple Tips to Eat Healthy During the Holidays 2Health News:Vaccine for Deer Against 'Mad Cow'-Like Illness Shows Promise 2Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2
... , JACKSONVILLE, Fla., Aug. 18 ... Blue Cross and Blue Shield of Florida (BCBSF), announced today that ... receive funding from Partners Investing in Nursing,s Future , a ... nurses across the country. To date, this is the first Florida ...
... , New data show nanotechnology-related ... , WASHINGTON, Aug. 18 Every state can ... Data released today by the Project on Emerging Nanotechnologies ... organizations across all 50 U.S. states and in the District of ...
... , EDISON, N.J., Aug. 18 Digitek Medication ... various heart conditions, such as abnormal heart rhythms (atrial fibrillation & atrial ... potent that even a slight increase in dosage can be toxic or ... has suffered digitalis toxicity or symptoms associated with digitalis toxicity as a ...
... disordered breathing to deadly cardiovascular complications , TUESDAY, ... sleep apnea -- loud snoring, interrupted breathing and sleep ... and premature death among middle-aged and elderly men, according ... moderate sleep apnea face an increased death risk, as ...
... 10 physician groups in national experiment, U-M Faculty Group Practice demonstrates ... , ANN ARBOR, Mich., Aug. 18 Medicare patients ... getting better treatment than ever at the University of Michigan Health ... report. , , These results come from ...
... , , , , ... Mobility Solutions business of Motor o la, ... Motorola AirDefense Wireless Vulnerability Assessment solution , a ... networks. This innovative solution provides a completely new method to secure ...
Cached Medicine News:Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 2Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 3Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 4Health News:The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages 5Health News:Putting Nanotechnology on the Map 2Health News:Putting Nanotechnology on the Map 3Health News:Digitek Medication Recalled Due to Risk of Digitalis Toxicity 2Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 2Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 3Health News:Sleep Apnea Raises Risk of Death, Especially for Men: Report 4Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 2Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 3Health News:U-M Improved Preventive and Chronic Care and Saved Medicare $$ 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 2Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 3Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 4Health News:Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing 5
(Date:12/22/2014)... 22, 2014 TWi Biotechnology, Inc., today ... for AC-201, TWi Biotechnology,s lead drug candidate, from ... China for patent application numbered 201180018154.8.  ... salts, active metabolite for treatment of type II ... treatment using AC-201 for type II diabetes, and ...
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... 2014 In today,s increasingly global marketplace ... to reflect the needs of a global marketplace ... the needs of key stakeholders while recognizing regional ... According to recent research by benchmarking firm, Best ... companies averaged more than $100,000 in annual spending ...
Breaking Medicine Technology:TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2
... Pa., July 28, 2011 Kensey Nash Corporation (Nasdaq: ... earnings results for its fourth quarter and fiscal year ended ... August 18, 2011.   Joe Kaufmann, President and ... on Thursday, August 18, 2011 at 9:00 A.M. Eastern Time. ...
... 2011 Questcor Pharmaceuticals, Inc. (NASDAQ:  QCOR) announced today that ... to be held August 9-11, 2011 at the InterContinental Boston ... Officer, is scheduled to present an overview of the Company ... To listen to the audio web cast of ...
Cached Medicine Technology:Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference 2Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011 2
... Accutest H. pylori WB test ... the qualitative detection of lgG ... in human whole blood. This ... an aid in the diagnosis ...
... is an FDA approved rapid ... blood test used to aid ... infection. This CLIA waived test, ... antibodies to HIV-1, requires only ...
... QuickVue+ Infectious Mononucleosis test is ... antibodies in serum, plasma or whole ... utilizes an extract of bovine erythrocytes ... specificity than similar extracts prepared from ...
... the first available point-of-care diagnostic test that ... of influenza A and B. The test ... an enzyme that assists viral replication by ... infected cells. The ZstatFlu substrate is labeled ...
Medicine Products: